PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to ShareholdersBusiness Wire • 01/15/26
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segmentsMarket Watch • 01/15/26
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial ResultsPRNewsWire • 01/15/26
Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Stocks At New Highs: Industrials Allient, Wabtec And A Health Care Name Trade In Or Near Buy ZonesInvestors Business Daily • 12/19/25
Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/03/25
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare ConferencePRNewsWire • 11/19/25
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins ExpandZacks Investment Research • 11/11/25
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 11/06/25
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary EmbolismPRNewsWire • 11/03/25
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary EmbolismPRNewsWire • 10/27/25
Penumbra, Inc. (PEN) Presents at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 TranscriptSeeking Alpha • 10/27/25